![](https://media.asiaone.com/sites/default/files/styles/a1_600x316/public/original_images/Jul2024/pr-newswire_500_4_2256.jpg?h=7de12b8a&itok=J3vINJe2)
NEURIM PHARMACEUTICALS RECEIVES POSITIVE CHMP OPINION ON SLENYTO® (PEDIATRIC PROLONGED-RELEASE MELATONIN) FOR THE ...
TEL-AVIV, Israel, July 30, 2024 /PRNewswire/ -- Neurim Pharmaceuticals ("Neurim") announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending …